Max Robotics — Global Service Robot Directory + US Certification

About

Neehar D. Parikh is a leading hepatologist whose research focuses on the diagnosis, risk stratification, and management of hepatocellular carcinoma (HCC), as well as innovative non-invasive therapies for liver tumors. He has made major contributions to the field by spearheading the #HOPE4LIVER single-arm pivotal trial, a landmark study evaluating histotripsy—a novel, non-thermal focused ultrasound therapy that liquefies tissue—for primary and metastatic liver tumors. This work, published in 2025 and already cited 30 times, demonstrates his role in advancing cutting-edge, non-invasive treatment paradigms. Dr. Parikh has also shaped clinical practice through his involvement in the INASL Consensus on Management of HCC, helping to navigate the rapidly evolving therapeutic landscape. His research has been instrumental in improving early detection and personalized care for liver cancer patients. With a citation count reflecting his influence, Dr. Parikh’s achievements include leading pivotal trials and contributing to national consensus guidelines, making him a key figure in hepatology and a valuable resource for students and researchers interested in liver cancer innovation.